Sarepta Therapeutics | SRPT - PE Price to Earnings


Sarepta Therapeutics reported 32.09 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
Acadia Pharmaceuticals 9.52 1.81 Sep/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 13.17 62.47 Sep/2026
Amgen 18.6 0.53 Sep/2026
BioCryst Pharmaceuticals 6.84 0.78 Jun/2026
Biogen 29.15 5.92 Sep/2026
BioMarin Pharmaceutical 53.62 32.55 Sep/2026
Capricor Therapeutics 2.76K 2.76K Dec/2022
Daiichi Sankyo 18.6 1.54 Sep/2026
Eli Lilly 64.5 31.61 Sep/2026
Gilead Sciences 17.68 4.18 Sep/2026
Incyte 54.54 40.08 Sep/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Moderna 27.22 14.51 Jun/2023
Neurocrine Biosciences 83.17 61.07 Sep/2026
Novavax 2.01 1.07 Dec/2025
Pfizer 15.2 3.72 Sep/2026
PTC Therapeutics 8.76 0 Jun/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Sanofi 22.34 3.38 Sep/2026
Sarepta Therapeutics 32.09 22.66 Sep/2026
Tectonic Therapeutic 4.01 0.63 Mar/2024
Vertex Pharmaceuticals 29.35 1.3 Sep/2026